Publicação
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
102 Curtidas5 Descurtidas10 Reposts1 Comentários
?
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
Ainda não há comentários. Seja o primeiro!
Comentários
Ainda não há comentários. Seja o primeiro!